Anticoagulation and Antiplatelet Regimen in Cardiac Transplant. Clinical Characteristics, Outcomes, and Blood Product Transfusion.
Maria Del Val Groba MarcoPedro Saavedra SantanaLuz Maria Gonzalez Del CastilloMario Galvan RuizMiguel de Fernandez de SanmamedStefano UrsoElisabet Guerra HernándezLaura Quintana ParisMichelle Tout CastellanoJose Luis Romero LujanEduardo Jose Caballero DortaLuisa Maria Guerra DominguezAntonio Garcia QuintanaPublished in: Clinical transplantation (2024)
In patients listed for CT requiring anticoagulation due to nonvalvular atrial fibrillation, the use of dabigatran and its reversal with idarucizumab significantly reduces intraoperative BPT demand.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- left atrial
- end stage renal disease
- left atrial appendage
- direct oral anticoagulants
- ejection fraction
- heart failure
- newly diagnosed
- chronic kidney disease
- percutaneous coronary intervention
- computed tomography
- peritoneal dialysis
- patients undergoing
- image quality
- acute coronary syndrome
- adipose tissue
- pet ct